PMV Pharmaceuticals, Inc.

NASDAQ:PMVP

1.51 (USD) • At close September 13, 2024
Bedrijfsnaam PMV Pharmaceuticals, Inc.
Symbool PMVP
Munteenheid USD
Prijs 1.51
Beurswaarde 77,794,898
Dividendpercentage 0%
52-weken bereik 1.175 - 6.98
Industrie Biotechnology
Sector Healthcare
CEO Dr. David H. Mack Ph.D.
Website https://www.pmvpharma.com

An error occurred while fetching data.

Over PMV Pharmaceuticals, Inc.

PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is

Vergelijkbare Aandelen

Relmada Therapeutics, Inc. logo

Relmada Therapeutics, Inc.

RLMD

3.09 USD

Inogen, Inc. logo

Inogen, Inc.

INGN

11.33 USD

Rani Therapeutics Holdings, Inc. logo

Rani Therapeutics Holdings, Inc.

RANI

2.37 USD

Pharvaris N.V. logo

Pharvaris N.V.

PHVS

20.92 USD

Gossamer Bio, Inc. logo

Gossamer Bio, Inc.

GOSS

0.921 USD

Eagle Pharmaceuticals, Inc. logo

Eagle Pharmaceuticals, Inc.

EGRX

4.31 USD

Kiniksa Pharmaceuticals, Ltd. logo

Kiniksa Pharmaceuticals, Ltd.

KNSA

25.26 USD

Coherus BioSciences, Inc. logo

Coherus BioSciences, Inc.

CHRS

1.3 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)